DRUG · Mapped RxNorm record
Docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
NCT00253318
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
RAD001
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Dexamethasone
Normalized identity: dexamethasoneView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
DocetaxelDRUG · verified · RxNorm: docetaxel
RAD001DRUG
DexamethasoneDRUG · verified · RxNorm: dexamethasone
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
Novartis Pharmaceuticalscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00253318 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.